Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1465-1469
Published online before print August 1, 2002, doi: 10.1161/01.ATV.0000032007.14355.21
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/9/1465    most recent
01.ATV.0000032007.14355.21v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebenbichler, C.F.
Right arrow Articles by Patsch, J.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebenbichler, C.F.
Right arrow Articles by Patsch, J.R.
Related Collections
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1465.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women

C.F. Ebenbichler; M. Laimer; S. Kaser; A. Ritsch; A. Sandhofer; H. Weiss; F. Aigner; J.R. Patsch

From the Universitätsklinik für Innere Medizin (C.F.E., M.L., S.K., A.R., A.S., J.R.P.), Universität Innsbruck, Austria, and Universitätsklinik für Chirurgie (H.W., F.A.), Universität Innsbruck, Innsbruck, Austria.

Correspondence to Christoph F. Ebenbichler, MD, Universitätsklinik für Innere Medizin, Universität Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. E-mail Christoph.Ebenbichler{at}uibk.ac.at

Objective— Obesity is associated with increased morbidity and mortality from atherosclerotic disease. Lipid abnormalities contribute to the increased relative risk in obese subjects. Cholesteryl ester transfer protein (CETP) mass is increased in these patients and might mediate the atherogenic lipoprotein pattern observed in obesity.

Methods and Results— Twenty-one morbidly obese, middle-aged, female subjects participated in this prospective study. Subjects were examined before and 1 year after surgical treatment. Fat mass was determined by body impedance analysis; CETP mass, by ELISA; CETP activity, by exogenous substrate assay; and LDL particle diameter, by gradient gel electrophoresis. Mean weight loss after 1 year was 28.7 kg; mean fat mass loss was 22.6 kg. Mean CETP mass decreased from 1.81 to 1.32 µg/mL (P=0.008); mean CETP activity decreased from 244 to 184 nmol · mL-1 · h-1 (P=0.004); and in parallel, the mean diameter of LDL particles increased (256.8 to 258.4 Å, P=0.04).

Conclusions— We conclude that weight loss is associated with a pronounced decrease in CETP mass and activity and a consistent increase in LDL particle diameter. After 1 year of this prospective study in morbidly obese subjects undergoing weight loss by surgical treatment, it has been determined that some features of the atherogenic lipoprotein profile can be reversed.


Key Words: obesity • gastric banding • lipids • cholesteryl ester transfer protein




This article has been cited by other articles:


Home page
Eur Heart JHome page
W. Sturm, A. Tschoner, J. Engl, S. Kaser, M. Laimer, C. Ciardi, A. Klaus, H. Weiss, A. Sandhofer, J. R. Patsch, et al.
Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis
Eur. Heart J., August 2, 2009; 30(16): 2038 - 2043.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Forrester, R. Makkar, and P.K. Shah
Increasing High-Density Lipoprotein Cholesterol in Dyslipidemia by Cholesteryl Ester Transfer Protein Inhibition: An Update for Clinicians
Circulation, April 12, 2005; 111(14): 1847 - 1854.
[Abstract] [Full Text] [PDF]